STAT3 and neoplasm: Conversely, excessive Stat3 activation, through epithelial-specific Socs3 ablation or introduction of the Socs3-binding deficient gp130Y757F mutation, results in increased tumour burden both in terms of tumour size as well as incidence [68,85].